MSMartin Sollie

Martin Sollie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martin Sollie has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dry Liposuction for Upper-Extremity End-Stage Lymphedema: A Step-by-Step Video of Technique

    by Martin Sollie, Caroline Lilja, Christoffer Bing Ydo, Thomas Foged, Jens Ahm Sørensen, Jørn Bo Thomsen

    Lymphedema is a common, debilitating condition that challenges treatment efforts. The primary aim of treatment is to debulk the affected areas, providing relief without further damaging tissues or causing undesirable cosmetic outcomes. Liposuction has become a popular treatment for end-stage extremity lymphedema, yet there is no consensus on the most effective technique. Current practices include a range of methods such as dry, wet, superwet, laser-assisted, water-assisted, and power-assisted liposuction. Dry liposuction has sparked controversy, primarily due to concerns that it might be less gentle, and therefore potentially more harmful, than wet liposuction. Contrary to this, we posit that dry liposuction is a viable, low-risk alternative that minimizes the risk of tissue and lymph vessel damage while providing excellent and durable outcomes. This assertion is supported by current literature. In this video article, we present our systematic, step-by-step approach to performing dry liposuction for end-stage lymphedema, illustrating its efficacy and safety. Our personal experience is that patients experience significant reductions in limb volume and report high satisfaction rates, demonstrating that dry liposuction is both effective and reliable for the long-term management of end-stage lymphedema. Level of Evidence V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266


  • Open Access

    Gender-affirming genital surgery in the Nordic countries: Narrative review of current practices and challenges

    by Antti Mikkola, Isak Gran, Martin Sollie, Rikke Holmgaard, Kaisu Ojala, Hannes Sigurjonsson, Lucy Bai, Helena Sackey, Pehr Sommar, Jenny Löfgren

    Genital gender-affirming surgery is a crucial yet often overlooked component of gender-affirming care for transgender individuals. Genital gender-affirming surgery is a rapidly evolving field, and it is not uncommon for surgeons — sometimes without prior experience in gender-affirming care — to encounter transgender individuals in clinical practice; hence, it is essential that all healthcare providers possess a foundational understanding of gender-affirming procedures and individual’s needs. Research has shown that genital gender-affirming surgery significantly improves the quality of life for transgender individuals by aligning their physical characteristics with their gender identity. It can offer substantial satisfaction, both aesthetically and functionally. For transwomen, genital gender-affirming surgery enables them to wear underwear aligned with their gender identity, facilitates sexual function and the potential for vaginal intercourse. For transmen, it provides a more masculine appearance in the groin area, allows for penetrative intercourse with a reconstructed penis (neophallus), and in some cases enables urination while standing when combined with urethral lengthening. Today, a wide range of surgical options exists for both transwomen and transmen. Thorough preoperative counseling is essential when selecting the most appropriate reconstructive method. Advances in plastic, reconstructive, and microsurgery continue to expand these options, offering greater personalization and improved outcomes. While genital gender-affirming surgery is complex and often irreversible, individuals are generally highly satisfied with the results, particularly when they have realistic expectations prior to surgery. The aim of this narrative review is to provide an overview of genital gender-affirming surgery from a Nordic perspective. In the Nordic countries, gender-affirming care is highly centralized and integrated into publicly funded healthcare systems. The care programs across these countries share many similarities and are largely comparable in structure and approach.


  • Open Access

    Current practices and perspectives on gender-affirming breast and chest wall surgery in the Nordic region: An overview

    by Isak Gran, Antti Mikkola, Martin Sollie, Rikke Holmgaard, Kaisu Ojala, Hannes Sigurjonsson, Matteo Amoroso, Pehr Sommar, Louise Frisén, Jenny Löfgren, et al.

    This narrative review provides an in-depth description of gender-affirming breast surgery within the context of publicly funded healthcare systems in the Nordic countries. A comprehensive literature search was conducted in collaboration with two information specialists, focusing on original research, reviews, and clinical guidelines published in English. The prevalence of transgender and non-binary individuals in the Nordic region ranges from 0.04% to 0.6%, depending on the country and study methodology. Gender-affirming treatment, including hormone therapy and surgical interventions such as breast augmentation and mastectomy, plays a critical role in reducing gender dysphoria and improving psychological well-being, with low rates of reported regret. Transfeminine individuals often pursue breast augmentation with implants or autologous fat grafting; procedures tailored to their unique anatomical considerations. These surgeries are associated with improved health-related quality of life and high levels of satisfaction. Surgical planning involves careful consideration of implant type, placement, and incision strategy. Transmasculine individuals commonly undergo chest masculinization, with techniques adapted to breast size, ptosis, skin quality, and individual goals. Both implant-based and mastectomy procedures are generally safe, though complications such as capsular contracture, hematoma, or wound healing disturbances may occur. Although regret is rare, it underscores the need for comprehensive assessment, informed consent, and mental health support throughout the transition process. Breast cancer screening guidelines remain inconsistent, with barriers to access due to legal gender markers and varying levels of provider knowledge While Nordic countries vary in their approaches, all aim to balance medical necessity, individual autonomy, and healthcare equity. Future priorities include refining surgical protocols, expanding research on long-term outcomes, and addressing systemic barriers to ensure inclusive, evidence-based care for all gender-diverse individuals.


  • Open Access

    Gender-affirming healthcare in the Nordic countries: An overview

    by Isak Gran, Cecilia Dhejne, Antti Mikkola, Martin Sollie, Pehr Sommar, Rikke Holmgaard, Kaisu Ojala, Hannes Sigurjonsson, Louise Frisén, Jenny Löfgren, et al.

    This narrative review examines gender-affirming healthcare in the Nordic countries, highlighting historical developments, legal frameworks, epidemiological trends, and current clinical practices. Transgender healthcare dates back to the early 20th century and gained international attention in the early 1950s following one of the first widely publicized gender-affirming surgeries performed in Denmark. Since then, care models have evolved, supported by policy, research, and clinical practice across Europe and North America. All Nordic countries, Denmark, Finland, Iceland, Norway, and Sweden, provide publicly funded gender-affirming healthcare, although service structures differ. Legal gender recognition has shifted toward self-identification in Denmark, Finland, Iceland, Norway, and from July 2025, also Sweden by removing medical or psychiatric prerequisites. In parallel, epidemiological data reveal an increased healthcare utilization, particularly among youth assigned female at birth. Elevated rates of mental health challenges highlight the need for integrated psychosocial support. Clinical care typically follows a multidisciplinary model including psychiatric and medical assessment, hormone therapy, and surgery when indicated. Access to chest and genital surgery requires a formal diagnosis and is with few exceptions restricted to adults. Evidence supports the positive impact of gender-affirming treatment on gender congruence and health-related quality of life. Regret after gender-affirming surgery is rare but does occur, underscoring the importance of individualized care and thorough informed consent. Ongoing challenges include long wait times, unequal access for non-binary individuals, and a growing number of individuals seeking private or cross-border care. Future efforts should focus on expanding public services, strengthening research, and promoting equitable, evidence-based care that reflects the diversity of gender identities.


  • Open Access

    Comparison of Patient-Reported Quality of Life Following Direct-to-Implant Prepectoral and Subpectoral Breast Reconstruction Using BREAST-Q: A Randomized Controlled Trial

    by Diana Lydia Dyrberg, Farima Dalaei, Martin Sollie, Camilla Bille, Vibeke Koudahl, Jens A Sørensen, Jørn Bo Thomsen

    Background Direct-to-implant breast reconstruction (DIR) is becoming more and more accepted. There is a lack of high-quality studies assessing differences in patient-reported quality of life (QoL) between different implant placement methods. The aim of this randomized controlled (clinical) trial was to compare QoL between women reconstructed by sub- or prepectoral implant placement. Methods We included women over 18 years eligible for DIR. Patients were randomly assigned to reconstruction by subpectoral or prepectoral implant placement. Assessment of QoL and patient satisfaction was made using the BREAST-Q questionnaire for postmastectomy breast reconstruction and compared between the sub- and prepectoral reconstructed groups preoperatively and after 3 and 12 months of follow-up. Results A total of 42 women were allocated to sub- or prepectoral reconstruction with 21 patients in each group. There were no differences in patient characteristics between groups. Regarding all the selected BREAST-Q scales: (1) satisfaction with the reconstructed breast, (2) satisfaction with the breast implant, (3) satisfaction with the overall outcome, (4) psychosocial well-being, (5) sexual well-being, and (6) physical well-being—we found no significant differences between the two groups. Assessing each group independently we found, that in both groups sexual well-being improved after surgery postoperatively compared to the preoperative scores. Conclusion We found high satisfaction and QoL following both sub- and prepectoral breast reconstruction. We found no significant differences between groups suggesting both methods for DIR can be used. Despite our high-quality data, a larger sample size and longer postoperative follow-up are needed to further investigate the differences in QoL between sub- and prepectoral breast reconstruction.


  • Open Access

    Attending a patient education seminar before body-contouring surgery and its effect on total time admitted to hospital and postsurgical opioid use - a retrospective cohort study

    by Signe Poulsen, Martin Sollie

    Objective: To investigate whether attending a one-day patient education seminar before body-contouring surgery after massive weight loss surgery could affect postsurgical opioid use and the total time admitted to the hospital. Secondly, we wanted to see if other patient characteristics could influence the above variables. Methods: We conducted a retrospective chart review of all patients undergoing body-contouring surgery at our department from April 2017 to December 2020. All patients had been invited to attend our patient education seminar prior to surgery, with around half accepting the invitation. Results: We included a total of 276 patients. One hundred fifty patients had attended the patient education seminar and were compared to the one hundred and twenty-six who did not participate. Attending a patient education seminar prior to body-contouring surgery was associated with reduced total admission time after surgery. It did not affect the use of postoperative analgesics. Previous gastric bypass and previous body-contouring surgery were associated with a shorter duration of stay. Males reported higher use of analgesics compared to women. More extensive surgery, such as abdominoplasty and circular body lift, was associated with a longer stay duration than more minor procedures such as thighplasty, upper arm lift, and chest correction. Conclusion: Our results indicate that attending a patient education seminar could reduce the total admission time in relation to their body-contouring surgery. As a result of this study, we have made participation in the patient education seminar mandatory before body-contouring surgery. Practice implications: Healthcare personnel should be aware of the importance of proper pre-operative preparation and, if feasible, arrange a patient education seminar. They should also be aware of other factors that could affect hospital admission time, such as previous gastric bypass and previous body-contouring surgery. The area of surgery and gender of the patients could also affect the need for analgesics after surgery.

  • Open Access

    Health Technology Readiness amongst Patients with Suspected Breast Cancer Using the READHY-tool - a Cross-sectional Study

    by Martin Sollie, Marianne Hansen, Jørn Bo Thomsen

    Information technologies are increasingly used when informing patients about their disease, treatment and prognosis. These digital platforms have many advantages compared to traditional education interventions. However, there are concerns that some patients may have difficulty with this mode of information delivery. Newly diagnosed breast cancer patients are dependent on understanding their treatment options to make informed treatment decisions. Yet, there is a lack of published material on breast cancer patients and their relationship with technology. We aimed to assess health technology readiness profiles amongst women with a suspected breast cancer diagnosis. Secondly, we wanted to investigate the potential differences between these profiles according to sociodemographic factors and the patients´ current use of technology. This cross-sectional study used the Readiness and Enablement Index for Health Technology (READHY) questionnaire. We included all patients (n = 92) referred to our department with suspected breast cancer. Cluster analysis revealed three distinct profiles: medium (n = 54), high (n = 18), and low (n = 20) health technology readiness. The third profile showed difficulties in health literacy, eHealth literacy, and health insights, along with higher emotional stress. Our study found that most patients had medium to high health technology readiness, but we also identified a group with lower health technology readiness. Based on our results, healthcare personnel dealing with women with suspected breast cancer should be aware of patients struggling with health technology. Age and technology familiarity may indicate vulnerable patients. Future studies should explore optimal methods for information delivery to these distinct profiles and evaluate the long-term impacts.


  • Open Access

    Health Technology Readiness amongst Patients with Suspected Breast Cancer Using the READHY-tool - a Cross-sectional Study

    by Martin Sollie, Marianne Hansen, Jørn Bo Thomsen

    Purpose Information technologies are increasingly used when informing patients about their disease, treatment and prognosis. These digital platforms have many advantages compared to traditional education interventions. There are concerns that some patients may have difficulty with this mode of information delivery. This warrants the question; are our patients ready for the transition towards more digital information technologies? We aimed to assess health technology readiness profiles amongst women with a suspected breast cancer diagnosis. Secondly, we wanted to investigate the potential differences between these profiles according to sociodemographic factors and the patients´ current use of technology. Methods This cross-sectional study used the Readiness and Enablement Index for Health Technology (READHY) questionnaire. We included all patients (n=92) referred with suspected breast cancer. Results The cluster analyses identified three distinct profiles. Patients in profile 1 (n=54) demonstrated medium health technology readiness. Profile 2 (n=18) reported high scores on all parameters. Profile 3 (n=20) scored lowest on all parameters indicating problems with health literacy, eHealth literacy and insight into their health. Profile 3 also reported higher levels of emotional stress. Conclusions Our study found that most patients had medium to high health technology readiness, but we also identified a group with lower health technology readiness. Based on our results, healthcare personnel dealing with women with suspected breast cancer should be aware of patients struggling with health technology. Age and technology familiarity may indicate vulnerable patients. More studies investigating different modes of information delivery with follow-ups are needed.

  • Open Access

    Surgical treatment of severe refractory Acne Keloidalis Nuchae with excision and reconstruction by immediate split-thickness skin graft and negative pressure wound therapy: a case report. (Preprint)

    by Anne Mie Friis-Rødel, Sinem Saritas, Martin Sollie

    UNSTRUCTURED Acne Keloidalis Nuchae (AKN) is a chronic inflammatory condition which in vast majority of cases is treated medically. In rare cases where the condition is severe and refractory to treatment, surgical intervention is necessary. There is still no consensus on the best surgical method of treatment, but the wish for a short postoperative healing period and a cosmetically acceptable result is the same for all cases. In this case we present a patient with severe refractory AKN, treated with excision and direct Split-Thickness Skin Grafting (STSG) in combination with Negative Pressure Wound Therapy (NPWT). This, with a both shorter healing period than previously described and with a satisfactory cosmetic result.

  • Autologous Fat Grafting Is Not Superior to Placebo as Treatment of Postherpetic Neuralgia: A Double-Blind Randomized Clinical Trial

    by Martin Sollie, Jørn B. Thomsen, Jens A. Sørensen

    Background: Postherpetic neuralgia (PHN) is a chronic pain syndrome occurring after a herpes zoster outbreak. While there is no effective treatment available today, autologous fat grafting has shown promise. This randomized controlled trial investigated the effectiveness of fat grafting as treatment for PHN compared with a sham treatment. Methods: A total of 46 participants with PHN were included. After liposuction under general anesthesia, participants were randomly assigned to receive either autologous fat grafting or saline injection to the area of pain. The primary outcomes were the average and maximum degree of pain measured on an 11-point numeric rating scale. Secondary outcomes were quality and degree of neuropathic pain (Neuropathic Pain Symptom Inventory) and quality of life (36-Item Short-Form Health Survey). Results: Forty-two participants completed follow-up of 6 months. For maximal degree of pain, a reduction of −1.1 ± 0.6 and −1.0 ± 0.5 mean change (±SE) on the numeric rating scale was observed in the intervention and control groups, respectively. For average degree of pain, the reduction was −1.2 ± 0.5 and −1.3 ± 0.4 in the intervention and control groups, respectively. The authors did not observe any significant changes in the neuropathic pain and quality-of-life parameters. For all measured outcomes, the differences between the groups were not statistically significant. Conclusions: The authors did not find autologous fat grafting superior to a placebo when treating PHN of the skin. Given their results, they cannot recommend the routine use of this method to treat these pains. Clinical Relevance Statement: Since autologous fat grafting was not proven to be more effective than a placebo in treating PHN, alternative treatment options should be explored. It is also essential to emphasize the importance of prophylactic vaccination against herpes zoster. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.